Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jul 2;2(1):36.
doi: 10.1186/2191-219X-2-36.

[11C]phenytoin revisited: synthesis by [11C]CO carbonylation and first evaluation as a P-gp tracer in rats

Affiliations

[11C]phenytoin revisited: synthesis by [11C]CO carbonylation and first evaluation as a P-gp tracer in rats

Joost Verbeek et al. EJNMMI Res. .

Abstract

Background: At present, several positron emission tomography (PET) tracers are in use for imaging P-glycoprotein (P-gp) function in man. At baseline, substrate tracers such as R-[11C]verapamil display low brain concentrations with a distribution volume of around 1. [11C]phenytoin is supposed to be a weaker P-gp substrate, which may lead to higher brain concentrations at baseline. This could facilitate assessment of P-gp function when P-gp is upregulated. The purpose of this study was to synthesize [11C]phenytoin and to characterize its properties as a P-gp tracer.

Methods: [11C]CO was used to synthesize [11C]phenytoin by rhodium-mediated carbonylation. Metabolism and, using PET, brain pharmacokinetics of [11C]phenytoin were studied in rats. Effects of P-gp function on [11C]phenytoin uptake were assessed using predosing with tariquidar.

Results: [11C]phenytoin was synthesized via [11C]CO in an overall decay-corrected yield of 22 ± 4%. At 45 min after administration, 19% and 83% of radioactivity represented intact [11C]phenytoin in the plasma and brain, respectively. Compared with baseline, tariquidar predosing resulted in a 45% increase in the cerebral distribution volume of [11C]phenytoin.

Conclusions: Using [11C]CO, the radiosynthesis of [11C]phenytoin could be improved. [11C]phenytoin appeared to be a rather weak P-gp substrate.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic overview of the synthesis unit used to synthesize [11C]CO.
Scheme 1
Scheme 1
The synthesis of azidodiphenylacetamide 3. (i) Triflyl azide, K2CO3, Cu(II)SO4·5H2O, CH2Cl2, CH3OH, 16 hr, room temperature (RT), 75% yield. (ii) SOCl2, CH3CN, 90 min, reflux. (iii) NH4, CH3CN, 16 hr, RT, 76% yield.
Figure 2
Figure 2
Retention time of [11C]CO2on silica gel with varying mass percentages of water. The silica gel was prepared by drying for 16 h at 120°C, after which water was added.
Figure 3
Figure 3
Rhodium sources used: (Rh(cod)2) and rhodium(II) acetate dimer.
Figure 4
Figure 4
Phosphine ligands used: triphenylphosphine, DPPE and DPPP.
Scheme 2
Scheme 2
Radiolabeling of [11C]phenytoin 4. (i) [11C]CO, Rh(II) acetate dimer, DPPE, THF, 5 min, 250 bar, 120°C, 22 ± 4% overall yield.
Figure 5
Figure 5
Typical preparative HPLC chromatogram with UV absorption (upper panel) and radioactivity (lower panel) signals.
Figure 6
Figure 6
Summed (10 to 60 min) images of [11C]phenytoin in the rat brain. Before (second image) and 15 min after (third image) intravenous administration of tariquidar (15 mg·kg−1) in the rat. The brain is outlined in both images. Regions of interest used in the analysis are shown on an MR template image (left); the overlay image is shown on the right.
Figure 7
Figure 7
[11C]phenytoin time-activity curves in selected rat brain regions. Baseline (open symbols) and after administration of tariquidar (closed symbols). The injected dose was 17.1 ± 2.1 MBq. Error bars represent standard deviation.

Similar articles

Cited by

References

    1. Cordon-Cardo C, O’Brien JP, Casals D, Rittman-Grauer L, Biedler JL, Melamed MR, Bertino JR. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood–brain barrier sites. Proc Natl Acad Sci U S A. 1989;86:695–698. doi: 10.1073/pnas.86.2.695. - DOI - PMC - PubMed
    1. Pike VW. PET radiotracers: crossing the blood–brain barrier and surviving metabolism. Trends Pharmacol Sci. 2009;30(8):431–440. doi: 10.1016/j.tips.2009.05.005. - DOI - PMC - PubMed
    1. Löscher W, Sills GJ. Drug resistance in epilepsy: why is a simple explanation not enough? Epilepsia. 2007;48:2369–2378. doi: 10.1111/j.1528-1167.2007.01260_1.x. - DOI - PubMed
    1. Luna-Tortos C, Fedrowitz M, Löscher W. Several major antiepileptic drugs are substrates for human P-glycoprotein. Neuropharmacology. 2008;55:1364–1375. doi: 10.1016/j.neuropharm.2008.08.032. - DOI - PubMed
    1. Löscher W, Potschka H. Role of multidrug transporters in pharmacoresistance to antiepileptic drugs. J Pharmacol Exp Ther. 2002;301:7–14. doi: 10.1124/jpet.301.1.7. - DOI - PubMed

LinkOut - more resources